Latest goodwill for ERYP: $0.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Erytech Pharma's goodwill stands at $0 as of March 2023. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.
Open the history chart to see whether Erytech Pharma's goodwill is expanding or contracting. Sustained growth in goodwill can support a stronger franchise, while sharp declines may reflect divestitures, weaker demand, or accounting changes. Always read YoY moves with the footnotes of recent filings in mind.
The history chart shows how Erytech Pharma's goodwill evolved across reporting periods, while the comparison chart places ERYP next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.
Yes — within Healthcare, goodwill is commonly used to spot outliers. Erytech Pharma's reading of $0 is a starting point; confirm whether differences come from growth, margins, accounting choices, or one-time items before treating an outlier as a buy or sell signal.